Aberdeen Group’s Alkermes ALKS Stock Holding History

Aberdeen Group’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.2M	Buy	+193,805	New	+$7.57M	0.01%	594
2025 Q4	–	Sell	-146,224	Closed	-$4.39M	–	941
2025 Q3	$4.39M	Sell	146,224 -32,495	-18%	-$916K	0.01%	717
2025 Q2	$5.11M	Buy	178,719 +21,852	+14%	+$650K	0.01%	700
2025 Q1	$5.18M	Sell	156,867 -87,452	-36%	-$2.85M	0.01%	678
2024 Q4	$7.03M	Sell	244,319 -148,223	-38%	-$4.26M	0.01%	579
2024 Q3	$11M	Sell	392,542 -16,438	-4%	-$438K	0.02%	505
2024 Q2	$9.86M	Buy	408,980 +134,213	+49%	+$3.29M	0.02%	514
2024 Q1	$7.44M	Sell	274,767 -48,668	-15%	-$1.38M	0.01%	601
2023 Q4	$8.97M	Buy	+323,435	New	+$8.4M	0.02%	567
2019 Q3	–	Sell	-20,622	Closed	-$464K	–	921
2019 Q2	$464K	Buy	20,622 +568	+3%	+$15.6K	﹤0.01%	884
2019 Q1	$732K	Buy	20,054 +11,703	+140%	+$386K	﹤0.01%	838
2018 Q4	$242K	Sell	8,351 -86	-1%	-$3.17K	﹤0.01%	870
2018 Q3	$358K	Sell	8,437 -189	-2%	-$8.2K	﹤0.01%	891
2018 Q2	$355K	Buy	+8,626	New	+$393K	﹤0.01%	881

Other funds holding ALKS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Aberdeen Group's ALKS Position: Q2 2026 in Review

Aberdeen Group opened a new position in Alkermes (ALKS) in Q2 2026: 193,805 shares worth $10.2M. The stake represents 0.01% of the portfolio and ranks #594 among its holdings. This is a return to the name: Aberdeen Group previously reported a position in ALKS as recently as Q3 2025.

Aberdeen Group first reported a position in ALKS in Q2 2018 and has held it in 14 quarters since. The position peaked at $11M in Q3 2024. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

Aberdeen Group held 193,805 shares of Alkermes worth $10.2M as of Q2 2026.
Alkermes was a new Aberdeen Group position in Q2 2026.
Alkermes made up 0.01% of Aberdeen Group's portfolio in Q2 2026, its #594 holding.
Aberdeen Group first reported a position in Alkermes in Q2 2018 and has held it in 14 quarters since.
Aberdeen Group's Alkermes position peaked at $11M in Q3 2024.
424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.